President’s Message

As always, we have a fantastic line up this year, and it will be a wonderful opportunity to socialize with your professional colleagues.

This year’s program features clinical sessions by experts in the fields of autoinflammatory diseases, rheumatoid arthritis, Psoriatic Arthritis, as well as important advocacy issues vital to rheumatology. After careful months of planning, we have assembled a list of speakers who will share their vast experiences with us.

We’re pleased to have Michelle Petri, MD, MPH from the Johns Hopkins University School of Medicine, who will present an Update on SLE. Excluding her clinical interest in Systemic Lupus Erythematosus, her research interests include antiphospholipid antibodies, coronary artery disease, the measurement of lupus disease activity, and the longitudinal study of the predictive value of complement split products as laboratory measure of disease in lupus.

Our top-notch faculty also includes Northwestern University’s Eric M. Ruderman, MD, who will be presenting “SpA/Psoriatic Arthritis.” Dr. Ruderman’s clinical focus is on Rheumatoid Arthritis, Psoriatic Arthritis (combined with Dermatology) and Spondyloarthritis. His academic focus is on linking clinical and research enterprises within the division to foster novel translation work that will advance the field of rheumatology.

We are also excited to have Dr. John J. Cush from the Baylor Research Institute. Dr. Cush will be giving a riveting discussion on the “Safety of Newer Agents.” Dr. Cush’s areas of clinical research include diagnostics, disease management, and therapeutic treatment, as well as drug safety, biologic therapies, and medical education.

In addition to our clinical sessions, we will have topics on State and Local Policy Updates, an ACR Advocacy Update, as well as Fellow Case Presentations.

This promises to be one of our best meetings ever.

Timothy Lonesky, DO
President, Kentuckiana Rheumatology Alliance